OBJECTIVE -To compare vibration perception thresholds (VPTs) obtained with two different instruments, a neurothesiometer and a vibratron, and to characterize variability of repeat measures and correlation with sural nerve conduction parameters.
Q uantitative determination of vibrotactile thresholds has been proposed as a method to assess the somatosensory pathways that transmit information induced by cutaneous vibratory stimuli (1) (2) (3) (4) . In comparison with conventional testing of vibration with a tuning fork, the quantitative method for measuring vibration perception thresholds (VPTs) has shown higher reliability, primarily because the equipment used minimizes the subjectivity of the examiner (5-7). Compared with electrophysiological testing, which measures peripheral nerve function directly and objectively, determination of quantitative vibrotactile thresholds is painless and requires brief training. Data obtained from quantitative sensory testing (QST) can be used in parametric statistical analyses and are particularly valuable in screening large populations or in longitudinal evaluation in clinical trials (2, 3, 7) . VPTs are used in clinical trials as an efficacy parameter, in addition to electrophysiological testing and clinical evaluations (8) (9) (10) . Few studies have shown a correlation between quantitative VPT and nerve conduction studies (NCSs) (2,7), and none have compared the following two commonly used instruments for detection of VPTs: the Vibratron II (Physitemp Instruments, Clifton, NJ) and the Horwell Neurothesiometer (Scientific Laboratory Supplies, Nottingham, U.K.).
In this prospective study, we compared the quantitative VPT measured with the Vibratron II and the Horwell Neurothesiometer and then assessed the relationship of each VPT to NCSs to determine which measurement most reliably reflects peripheral nerve function.
RESEARCH DESIGN AND
METHODS -A total of 152 patients (107 male, 45 female) with diabetic peripheral polyneuropathy who were enrolled in clinical trials received electrodiagnostic evaluation and quantitative VPT testing with the Vibratron II and the Horwell Neurothesiometer. Patients were age 55.5 ± 10.0 years (mean ± SD); 35 subjects were diagnosed with IDDM and 117 subjects with NIDDM. Duration of diabetes was 14.5 ± 9.9 years, and the mean duration of diabetic peripheral neuropathy was 4.2 ± 3.2 years. The Toronto Hospital Committee for Research in Human Subjects approved the trials. Each patient had both types of VPT measurements and NCS done on the same day. To compare reproducibility of the measurements, 42 patients returned for repeat testing performed on three different days.
NCSs were performed by a single person, who is a registered electromyogram (EMG) technologist at The Toronto Hospital, using the Dantec counterpoint. Recordings were optimized for temperature control (32-34°C), accurate distance measurements, and recording of well-defined and artifact-free-evoked responses. The sural response posterior to the lateral malleolus was recorded. Sensory potentials were averaged. We measured baselineto-peak amplitudes, onset latencies, and calculated conduction velocities for the sural nerve on one side, using a standardized technique.
Measurements of quantitative VPT with Vibratron II were performed using the two-alternative forced choice procedures (11) . Vibratron II has two rods, and the vibrating stimulus is randomly presented at one of the rods. Vibrating frequency for the rods was preset to 120 Hz. Before the testing, the procedure was explained to the patient, who had the opportunity to become familiar with the expected vibratory sensation. VPT was performed under standard conditions on both toes. For each trial, the vibration was present at only one rod and the patient was asked to determine, with the plantar surface of the toe, which of the rods was vibrating. The intensity sequence of the vibrating stimulus was determined by a testing algorithm. Testing was completed when the subject made a total of five errors. The next step was to determine the vibration settings of the five errors and the five lowest correct scores. The highest and the lowest value were eliminated, and the mean of the remaining eight scores were calculated to deduce the vibration threshold. Testing required -7-10 min per toe.
In comparison to the Vibratron II, the Horwell Neurothesiometer has just one rod. Vibrating frequency for the rod was preset to 50 Hz. Quantitative measurement of VPT was performed with the neurothesiometer using the method of limits procedure (11) . Again, the testing was explained to the patient, who had the opportunity to become familiar with the expected vibratory sensation. For each trial, the vibration stimulus started at zero and was gradually increased until the patient reported that he or she could feel the vibration. In addition, we did a catch trial, when no vibrating stimulus was presented. Three vibrating trials were performed per testing, and the final result was a mean of the three trials. The intensity and the speed of intensity change was under our control. Testing required ~2-3 min per toe.
A total of 42 patients returned for repeat testing on three separate days. These patients had three sets of NCSs, three sets of VPTs using the Vibratron II, and three sets of VPTs using the Horwell Neurothesiometer. The period between repeat testing ranged from 1 to 28 days.
Statistical analysis was performed using the Statview program for Macintosh. Regression analysis was used to test for significant associations between the two types of VPT measurements and sural nerve conduction parameters. RESULTS -The study population consisted of 152 subjects. The mean sural nerve amplitude was 4.7 ± 3.67 uV, while the mean for sural nerve conduction velocity was 38.9 ± 6.9 m/s. The mean neurothesiometer VPT was 26.6 ± 13.9 vibration units (volts) for the right toe and 26. The study population for the variability of repeat VPT testing consisted of 42 patients, who returned for repeat testing performed on three different days. Variability for the vibratron was 34% in the right first toe and 31% in the left first toe. Variability for the neurothesiometer was 8% for the right toe and 6% for the left toe. If vibration units were converted into micrometers, the variability for the vibratron and the neurothesiometer would be 61 and 56% and 16 and 12%, respectively (Table 1) . For the sural nerve conduction parameters, we found a variability of 2% for conduction velocity and 8% for amplitude in the 42 patients who had repeat testing.
Side-to-side correlations for the VPT were significantly high with an R 2 value of 0.549 with the vibratron and an R 2 value of 0.826 with the neurothesiometer. Using VPT in micrometers, side-to-side correlation is 0.520 for the vibratron and 0.791 for the neurothesiometer.
Correlation of the VPT units obtained with the vibratron to the neurothesiometer had an R 2 value of 0.362 for the right toes and 0.400 for the left toes.
VPT measurements from the vibratron correlated with the sural nerve amplitude, , and in micrometers they were 0.278 and 0.247. The higher correlation with conduction velocity rather than amplitude likely reflects more accuracy in sural conduction velocity measurements, compared with sural nerve amplitude measurements. All of these listed correlations were highly significant ( Table 2) .
We also found significant, but not very strong, correlations for VPT measured with the neurothesiometer for age, duration of diabetes, and duration of neuropathy For the vibratron, the only significant correlation that we found was between VPT measured at the left toe and duration of diabetic peripheral neuropathy.
CONCLUSIONS -Vibration perception thresholds are used in clinical and research settings. Testing of VPT with the neurothesiometer compared favorably to the biothesiometer in a previous report (12) . We used the neurothesiometer because it is digital.
Our data has shown that VPT determined with the neurothesiometer is less variable (8 and 6%) than with the vibratron (34 and 31%), and comparable with that in previous reports of the biothesiometer (13) and neurothesiometer (12) . VPT measurements with the vibratron and the neurothe-DIABETES CARE, VOLUME 20, NUMBER 9, SEPTEMBER 1997 Neurothesiometer and vibratron measuring siometer correlate significantly with peripheral nerve function, as demonstrated by sural nerve conduction parameters, with the neurothesiometer showing stronger correlations. Variability of nerve conduction studies done in a rigorous fashion is lower than either VPT method, reinforcing the use and benefits of nerve conduction studies.
Our results indicate that the neurothesiometer can be used reliably as complementary testing to NCSs in clinical trials and routine evaluation of patients with neuropathies. Easier, faster testing and better reflection of peripheral nerve function make the neurothesiometer the preferable instrument in our laboratory.
